Sabra Health Care Reit Inc SEC Filings

Sabra Health Care REIT, Inc. furnishes an investor presentation outlining recent investment activity, portfolio metrics, sustainability initiatives and capital structure. Year-to-date, Sabra has closed on $277 million of managed senior housing and skilled nursing investments at an estimated initial cash yield of 7.9%, and describes a pipeline of nearly $410 million in awarded investments at a 6.8% estimated initial yield. The company reports consolidated enterprise value of $7.8 billion as of March 31, 2026, supported by ample liquidity of about $1.2 billion and availability of $353.4 million under its at-the-market equity program. Key credit metrics include Net Debt to Adjusted EBITDA of 5.04x, an interest coverage ratio of 4.59x, weighted average debt maturity of roughly four years, and a 3.92% weighted average effective interest rate on permanent debt. Sabra also highlights portfolio diversification, favorable demographic tailwinds, environmental initiatives, and workforce diversity data.

Sabra Health Care REIT, Inc. director Michael J. Foster reported an insider transaction involving the company’s Common Stock. On May 22, 2026, he made a bona fide gift of 813 shares of Common Stock at a reported price of $0.00 per share. After this gift, Foster directly held 73,906 shares of Common Stock. He also indirectly held 42,411.745 shares of Common Stock through a 401(k) Plan. A footnote further states that his holdings include 715 unvested stock units and 53,484 vested but deferred stock units, each representing the right to receive one share of Common Stock.

Sabra Health Care REIT Inc ownership disclosure: Vanguard Capital Management reports 13,315,431 shares of Common Stock, representing 5.28% of the class as of the filing. The filer states sole dispositive power over 13,315,431 shares and sole voting power over 2,084,683 shares. The disclosure lists affiliated Vanguard entities and notes holdings include securities held for Vanguard funds and managed accounts.

Sabra Health Care REIT reported higher first‑quarter results with total revenues of $221.8 million for the three months ended March 31, 2026, up from $183.5 million a year earlier, driven mainly by its Senior Housing - Managed portfolio.

Net income attributable to Sabra was $40.9 million, slightly above $40.3 million last year, with diluted earnings per share of $0.16. Operating cash flow rose to $98.4 million from $80.3 million, while the company invested $96.1 million to acquire three Senior Housing - Managed communities and one skilled nursing/transitional care facility.

As of March 31, 2026, Sabra owned 361 properties plus joint venture interests, with real estate investments, net, of $4.70 billion and total assets of $5.59 billion. Total debt was $2.69 billion, including a $355.0 million revolving credit facility balance and $1.25 billion of senior unsecured notes. The board declared a quarterly cash dividend of $0.30 per share.

Sabra Health Care REIT reported solid first quarter 2026 results and reiterated its full-year guidance. Net income attributable to common shareholders was $40.9 million, or $0.16 per diluted share. Key REIT metrics were stronger, with FFO of $0.37 and AFFO and Normalized AFFO of $0.39 per diluted share.

Same property managed senior housing Cash NOI rose 14.4% year over year, reflecting improving operating performance. Sabra invested $102.0 million in the quarter and $206.1 million year to date in senior housing and skilled nursing assets at an estimated initial cash yield of about 8.0%, and has been awarded an additional $200 million of higher-yielding opportunities.

Liquidity remained robust at approximately $1.2 billion as of March 31, 2026, including $116.5 million of cash, sizeable revolver capacity, and forward equity proceeds, while Net Debt to Adjusted EBITDA stood at 5.04x. The board declared a quarterly dividend of $0.30 per common share.

Sabra Health Care REIT Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 23,239,071 shares of Common Stock, representing 9.21% of the class as of 03/31/2026. The filing states this position reflects holdings across Vanguard affiliates and funds, "In accordance with SEC Release No. 34-39538 (January 12, 1998)".

Sabra Health Care REIT, Inc. has issued its 2026 proxy statement for the annual stockholder meeting on June 17, 2026 at its Tustin, California headquarters. Stockholders of record on April 14, 2026 may vote in person or by Internet, phone or mail.

Key items include electing directors, ratifying PwC as independent auditor for the year ending December 31, 2026, and a non-binding advisory vote on named executive officer compensation. The board is majority independent, uses majority voting for uncontested elections, provides proxy access, has no stockholder rights plan and has opted out of certain Maryland takeover defenses.

Executive pay is heavily performance-based, with about 65% of 2025 equity grant value in relative total stockholder return units, a five-year deferral and one-year post-vesting holding period, plus stringent stock ownership requirements of 10x base salary for the CEO and 5x for other executives. The proxy also highlights sustainability reporting, board and workforce diversity and formal oversight of human capital and ESG matters.

Sabra Health Care REIT Inc received an Schedule 13G/A (Amendment No. 15) from The Vanguard Group that reports zero beneficial ownership of its Common Stock. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 and is signed on 03/27/2026.

The filing lists Amount beneficially owned: 0 and Percent of class: 0%, with all voting and dispositive powers shown as 0.